Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study

scientific article published in January 2013

Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/MPA.0B013E31825ABF8C
P698PubMed publication ID22850624

P2093author name stringValery E P P Lemmens
Simon W Nienhuijs
Misha D Luyer
Ignace H J T de Hingh
Irene Thomassen
Yvonne L Klaver
P433issue1
P921main subjectperitoneal carcinomatosisQ2071182
P304page(s)72-75
P577publication date2013-01-01
P1433published inPancreasQ15762014
P1476titleIncidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study
P478volume42

Reverse relations

cites work (P2860)
Q92140598Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review
Q88735258Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway
Q90346763Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report
Q64108949Development and Biological Analysis of a Novel Orthotopic Peritoneal Dissemination Mouse Model Generated Using a Pancreatic Ductal Adenocarcinoma Cell Line
Q64063210Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC)
Q37013343Evaluation of expansile nanoparticle tumor localization and efficacy in a cancer stem cell-derived model of pancreatic peritoneal carcinomatosis
Q90244152FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study
Q47111181Highly Specific and Sensitive Fluorescent Nanoprobes for Image-Guided Resection of Sub-Millimeter Peritoneal Tumors
Q89471694Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study
Q40638288Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites
Q47809171Long-term survival with peritoneal mucinous carcinomatosis from intraductal mucinous papillary pancreatic carcinoma treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Q55220021Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids.
Q92617979Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC)
Q39171689Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.
Q39442876Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
Q90568096Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for the Diagnosis of Pancreatic Tumors
Q38958621Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
Q43880060Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors
Q38779523Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Q44424534Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma
Q35057350Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
Q37716482Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis
Q45228180Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection
Q40506490Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma
Q50795446Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients with peritoneal metastasis: a retrospective study in a single institution.
Q88709397The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy

Search more.